Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis
暂无分享,去创建一个
[1] R. Hruban,et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. , 1999, Medicine.
[2] A. Ramsingh,et al. T Cells Contribute to Disease Severity during Coxsackievirus B4 Infection , 1999, Journal of Virology.
[3] M. Martone,et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.
[4] N. Sarvetnick,et al. Protection from Lethal Coxsackievirus-Induced Pancreatitis by Expression of Gamma Interferon , 1999, Journal of Virology.
[5] C. Lowenstein,et al. An Antiviral Mechanism of Nitric Oxide , 1999, Immunity.
[6] T. Treasure,et al. Meta-analysis of the association of enteroviruses with human heart disease , 1997, Heart.
[7] Moses Rodriguez,et al. Primary demyelination in transgenic mice expressing interferon-γ , 1997, Nature Medicine.
[8] S. Hill,et al. The pathogenesis of postinfectious myocarditis. , 1996, Clinical immunology and immunopathology.
[9] C. Lowenstein,et al. Nitric oxide inhibits viral replication in murine myocarditis. , 1996, The Journal of clinical investigation.
[10] J. Whitton,et al. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis , 1995, Journal of virology.
[11] P. Hofschneider,et al. Investigation of the coxsackievirus B3 nonstructural proteins 2B, 2C, and 3AB: generation of specific polyclonal antisera and detection of replicating virus in infected tissue. , 1994, Journal of virological methods.
[12] T. Martino,et al. Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.
[13] S. Tracy,et al. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. , 1993, Clinical immunology and immunopathology.
[14] B. McManus,et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. , 1993, Clinical immunology and immunopathology.
[15] N. Sarvetnick,et al. Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. , 1993, Development.
[16] C. Gauntt,et al. Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential. , 1991, European heart journal.
[17] N. Sarvetnick,et al. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma , 1988, Cell.
[18] K. Beisel,et al. Postinfectious Autoimmunity: Two Distinct Phases of Coxsackievirus B3‐Induced Myocarditis a , 1986, Annals of the New York Academy of Sciences.
[19] K. Beisel,et al. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis , 1985, The Journal of experimental medicine.
[20] Y. Cao,et al. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice. , 1984, The Journal of general virology.
[21] M. Tatsumi,et al. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease. , 1983, British journal of experimental pathology.
[22] J. Melnick,et al. The histopathology of Coxsackie virus infection in mice. I. Morphologic observations with four different viral types. , 1952, The American journal of pathology.
[23] W. Mckenna,et al. Coxsackie B viruses and human heart disease. , 1997, Current topics in microbiology and immunology.
[24] B. McManus,et al. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.